Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 4—April 2015
Dispatch

Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010

Orna Mor, Ravit Bassal, Michal Michaeli, Marina Wax, Daniela Ram, Oranit Cohen-Ezra, Dani Cohen, Ella Mendelson, Ziv Ben-Ari, and Tamy Shohat
Author affiliations: Central Virology Laboratory, Ministry of Health, Ramat-Gan, Israel (O. Mor, M. Michaeli, M. Wax, D. Ram, E. Mendelson); Israel Center for Disease Control, Ministry of Health, Ramat-Gan (R. Bassal, T. Shohat); Sheba Medical Center, Ramat-Gan (O. Cohen-Ezra, Z. Ben-Ari); Tel-Aviv University, Tel-Aviv, Israel (D. Cohen, E. Mendelson, T. Shohat)

Main Article

Table 2

Multivariate logistic regression analysis for factors associated with anti HEV seropositivity, Israel, 2009–2010*

Characteristics

Odds ratio (95% CI)

p value

Age, y

<20

Reference

20–39

1.5 (0.1–24.3)

0.79

40–59

17.6 (2.2–143.8)

0.008

>60

100.1 (12.1–830.3)

<0.0001

Socioeconomic status

High, ranks 7–10

Reference

Intermediate, ranks 4–6

2.1 (0.7–5.7)

0.16

Low, ranks 1–3

3.4 (1.1–10.1)

0.03

Population group

Jew

Reference

Arab

7.1 (2.1–24.0)

0.002

Country of birth

Israel

Reference

Africa, FSU, Asia

3.8 (1.4–10.8)

0.1

*FSU, former Soviet Union.

Main Article

Page created: March 17, 2015
Page updated: March 17, 2015
Page reviewed: March 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external